LISA PENNINGTON: Open Payments
NPI 1710968557 · FLATWOODS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,239 in 133 payments from 20 companies in 2025. Trend: 2023 $1,437 · 2024 $1,665 · 2025 $2,239
Food & beverage: $2,239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $457 |
| PFIZER INC. | 29 | $453 |
| GlaxoSmithKline, LLC. | 18 | $225 |
| Novo Nordisk Inc | 10 | $198 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $140 |
| Lilly USA, LLC | 8 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Amgen Inc. | 2 | $54 |
Products named: NURTEC ODT, VRAYLAR, TRELEGY ELLIPTA, QULIPTA, ELIQUIS, XIFAXAN, MOUNJARO, REXULTI.
Industry payments across KY — which companies pay providers there.
